Clinical trial · Interventional
Study on Amino Acid Uptake in Brain Tumors
Phase 2 Study on Brain Tumor Uptake of the Amino Acid O-(2-[F-18]Fluorethyl)-L-Tyrosin (FET)
NCT00204295CI-TRIAL-00000444unknownPhase 2ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to determine the uptake of the amino acid O-(2-\[F-18\]Fluorethyl)-L-tyrosin (FET) in human brain tumors using positron emission tomography. A comparison to MRI and histopathological samples is used.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Brain Neoplasms | Brain Neoplasm | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| O-(2-[F-18]Fluorethyl)-L-Tyrosin (FET) - PET | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- Histological samples where available
- measure
- CD98 staining where available
Secondary outcomes (1)
- measure
- Clinical follow-up for at least one year
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 0 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with suspected primary brain tumors * CT or MRI showing lesion of \>= 2,5 cm * Any age; parents informed consent in children available * Karnofsky-Index \>= 20 % * Referral by Depts. of Neurology, Neuro-Oncology, Neurosurgery, or Pediatric Neurology at the UKM * Biopsy and/or surgery planned * Patient is able to lie during the PET scan for 50 minutes without moving • Patient must be able to give informed consent; signature must be present before the PET scan Exclusion Criteria: * Pregnancy or breast feeing * Patients, who by psychiatric disease are not able to give informed consent * Complete renal failure * Inclusion to other studies according to § 23 of the German radiation protection law
References
Publications (0)
Data not yet available
No reference posted for this study.